Marie-Emmanuelle
Marie-Emmanuelle Legrier, Paris FR
Patent application number | Description | Published |
---|---|---|
20130042333 | MARKERS FOR CANCER PROGNOSIS AND THERAPY AND METHODS OF USE - The invention relates generally to the field of cancer prognosis and treatment. More particularly, the present invention relates to methods and compositions that utilize a particular panel of gene products (“biomarkers”) and their differential expression patterns (“expression signatures”), wherein the expression patterns correlate with responsiveness, or lack thereof, to chemotherapy treatment. The invention is based on the identification of a specific set of biomarkers that are differentially expressed in chemotherapy-treated tumors and which are useful in predicting the likelihood of a therapeutic response, including residual disease persistence and subsequent tumor recurrence in cancer patients receiving chemotherapy. The gene panel is also useful in designing specific adjuvant modalities with improved therapeutic efficiency. Also disclosed are methods for characterizing tumors according to expression of the biomarkers described herein. | 02-14-2013 |
Marie-Emmanuelle Leguern, Compiegne FR
Patent application number | Description | Published |
---|---|---|
20090054643 | NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES - The invention relates to a method of preparation of fluoroquinolones of formula (I) from compounds of formula (II): | 02-26-2009 |
20090187034 | PROCESS FOR THE PREPARATION OF STIRIPENTOL PARTICLES HAVING A DEFINED PARTICLE SIZE DISTRIBUTION - The invention relates to a process for the preparation of stiripentol particles having a defined particle size distribution. | 07-23-2009 |
20130079336 | Treatment of Prolonged Status Epilepticus - Methods for terminating, preventing, and/or treating status epilepticus are generally provided. The method can include administering a prophylactically or therapeutically effective amount of stiripentol or a related compound thereof to an individual in need of treatment of status epilepticus. The individual can be in need of treatment of prolonged status epilepticus, refractory status epilepticus, and/or benzodiazepine-resistant status epilepticus. | 03-28-2013 |
Marie-Emmanuelle Le Guern, Compiegne FR
Patent application number | Description | Published |
---|---|---|
20090298817 | ANTI-AMNESIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM - The present invention relates to the use of at least one compound of formula (I) as follows: | 12-03-2009 |
20100144863 | COMPOUNDS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDERS - The present invention relates to a compound of the following formula (I): | 06-10-2010 |
20100197777 | Synergistic combination of analgesic compounds - The present invention relates to a pharmaceutical composition comprising as active substances: | 08-05-2010 |
20100240588 | COMPOUND FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIES - The present invention relates to a compound of the following formula (I): | 09-23-2010 |
20110135616 | Medicinal Product for Treating Gastrointestinal Ulcers - The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers. | 06-09-2011 |
20110136885 | Synergistic Combination of Analgesic Compounds - The present invention relates to a pharmaceutical composition comprising as active substances: | 06-09-2011 |